Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors [Phase 2]
The trial status shows completion of a Phase 2 multi-omics study evaluating the effects and mechanisms of acupuncture on psychoneurological …
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Analgesic Effect of Serratus Plane Block With Adjuvant Agents in Breast Cancer Surgery [Phase 2]
This Phase 2 trial update assesses the analgesic effect of serratus plane block with adjuvants in breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Trial of Exercise to Reduce Cancer Related Fatigue in Breast Cancer [NA]
A trial evaluating whether an exercise program reduces cancer-related fatigue in breast cancer patients has been terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation [NA]
Wake Forest University Health Sciences completed a trial comparing high-dose vitamin D to standard-dose vitamin D supplementation. The liste…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating the efficacy and safety of the trastuzumab biosimilar Herzuma plus physician's choice in patients with HER2-positiv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche) [Phase 1]
Phase 1 study comparing pharmacokinetics, immunogenicity, and safety of a trastuzumab biosimilar from Incepta Pharmaceuticals Ltd versus Roc…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer [Phase 1]
A Phase 1 trial evaluating copanlisib in combination with T-DM1 for pretreated unresectable locally advanced or metastatic HER2-positive bre…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Postoperative Pain, Central Sensitization, and Sleep Quality in Breast Cancer Surgery Patients
A clinical trial investigating postoperative pain, central sensitization, and sleep quality in breast cancer surgery patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer [Phase 2]
Phase 2 trial evaluating the impact of combining endocrine therapy with abemaciclib on host and tumor immune cell repertoire in advanced ER+…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies [Phase 1]
This Phase 1 study of NP-G2-044, a metastasis inhibitor, in patients with advanced or metastatic treatment-refractory solid tumors has compl…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Effectiveness of a Novel Low-level Laser Therapy Protocol in Managing Breast Cancer-Related Lymphedema [NA]
This trial assessed the effectiveness of a novel low-level laser therapy protocol for managing breast cancer-related lymphedema; the study h…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Oncologic Outcomes of Minimal Access Nipple-sparing Mastectomy Compared With Conventional Approach in Breast Cancer
A completed clinical trial comparing oncologic outcomes between minimal access nipple-sparing mastectomy and the conventional approach in br…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: T-Cell Therapy for Advanced Breast Cancer [Phase 1]
Phase 1 clinical trial update for a T-cell therapy in advanced breast cancer, including metastatic HER2-negative disease. The study status i…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease [Phase 3]
Phase 3 trial comparing Niraparib to placebo in HER2-negative breast cancer with BRCA mutation or triple-negative disease, with results repo…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
This completed clinical trial analyzed the role of surgical intervention for patients presenting with stage IV breast cancer, exploring its …
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating melatonin in breast cancer patients undergoing neoadjuvant chemotherapy. The study is current…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors [Phase 2]
Phase 2 clinical trial evaluating oxaloacetate for improving cognitive complaints in early-stage breast cancer survivors has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer [Phase 3]
A Phase 3 trial evaluating abemaciclib in combination with hormone therapy for early breast cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial ELVN-002 for HER2-mutant non-small cell lung cancer and HER2-positive metastatic breast cancer is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant SBRT followed by nab-paclitaxel plus toripalimab in HR+/HER2- breast cancer is currently rec…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Effectiveness of a Combined Diet and Mindfulness Program on Weight Loss in Breast Cancer Survivors [NA]
Completed clinical trial evaluating the effectiveness of a combined diet and mindfulness program for weight loss in breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer [Phase 4]
A Phase 4 trial comparing two standard-of-care cardiac monitoring schedules for patients receiving trastuzumab for early-stage breast cancer…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Catheter Tip Position and Contrast Distribution Following Paravertebral Catheter Insertion: a CT Study
A completed CT study evaluating catheter tip position and contrast distribution after paravertebral catheter insertion in breast cancer pati…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab [Phase 2]
Phase II clinical trial evaluating carboplatin and paclitaxel with either pertuzumab and trastuzumab or bevacizumab for breast cancer; the s…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 [NA]
This clinical trial update reports on a completed study evaluating bone mineral density in women with breast cancer treated with triptorelin…